Harmony Biosciences Holdings (HRMY) Non-cash Items (2024 - 2026)
Harmony Biosciences Holdings' (HRMY) quarterly Non-cash Items came in at $16.3 million in Q1 2026, up 249.02% year-on-year from $4.7 million in Q1 2025, and down 68.62% quarter-over-quarter from $52.0 million in Q4 2025.
Harmony Biosciences Holdings (HRMY) Non-cash Items (2024 - 2026) Analysis & Trends
Harmony Biosciences Holdings has disclosed Non-cash Items across 3 years of filings, most recently posting $16.3 million for Q1 2026.
- Non-cash Items for Q1 2026 came in at $16.3 million, up 249.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.3 million (up 249.02% YoY), and the FY2025 annual result was $52.0 million, up 1075.26% from the prior year.
- Non-cash Items came in at $16.3 million for Q1 2026 at Harmony Biosciences Holdings, down from $52.0 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $52.0 million in Q4 2025 to a low of $4.3 million in Q3 2024.
- The 3-year median for Non-cash Items is $10.9 million (2025), against an average of $18.1 million.
- Peak annual rise in Non-cash Items reached 1075.26% in 2025, while the deepest fall reached 6.84% in 2025.
- Harmony Biosciences Holdings' Non-cash Items stood at $4.4 million in 2024, then jumped by 1075.26% to $52.0 million in 2025, then plunged by 68.62% to $16.3 million in 2026.
- The last three Non-cash Items figures came in at $16.3 million (Q1 2026), $52.0 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.30 Mn |
| Mar 31, 2026 | 16.30 Mn |
| Dec 31, 2025 | 51.95 Mn |
| Dec 31, 2025 | 51.95 Mn |
| Sep 30, 2025 | 5.53 Mn |
| Sep 30, 2025 | 5.53 Mn |
| Jun 30, 2025 | 29.80 Mn |
| Jun 30, 2025 | 29.80 Mn |
| Mar 31, 2025 | 4.67 Mn |
| Mar 31, 2025 | 4.67 Mn |
| Dec 31, 2024 | 4.42 Mn |
| Dec 31, 2024 | 4.42 Mn |
| Sep 30, 2024 | 4.32 Mn |
| Sep 30, 2024 | 4.32 Mn |
| Jun 30, 2024 | 27.89 Mn |
| Jun 30, 2024 | 27.89 Mn |